Antisense Technology

An Innovative Platform for Discovering First-in-Class Drugs for Treating Disease

Antisense technology represents an important breakthrough in the way we treat disease. The explosion in genomic information led to the discovery of many new disease-causing proteins and created new opportunities accessible only to antisense technology.

We have led the industry in the development of RNA-based technologies and successfully developed a drug discovery platform based on our antisense technology. We discover and develop drugs that bind to RNA instead of proteins, which have been the focus of the pharmaceutical industry for more than 100 years.

For information on the targets and the mechanisms by which antisense drugs work read more here

Discovery Platform

Learn about antisense drugs and what makes them work.

Learn More

Intellectual Property

We have one of the largest and most valuable nucleic acid therapeutics-oriented patent estates in the pharmaceutical industry.

Learn More

Publications

A snapshot of Isis' ground-breaking research.

Learn More